TriSalus Life Sciences PE Ratio 2021-2025 | TLSI

Current and historical p/e ratio for TriSalus Life Sciences (TLSI) from 2021 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. TriSalus Life Sciences PE ratio as of May 23, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

TriSalus Life Sciences PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-05-23 5.56 0.00
2025-03-31 5.52 $-1.12 0.00
2024-12-31 5.01 $-1.33 0.00
2024-09-30 4.61 $-2.49 0.00
2024-06-30 5.52 $-2.50 0.00
2024-03-31 9.75 $-2.29 0.00
2023-12-31 8.45 $-1.69 0.00
2023-09-30 5.12 $-0.13 0.00
2023-06-30 10.48 0 0.00
2023-03-31 10.20 0 0.00
2022-12-31 10.03 0 0.00
2022-09-30 9.93 0 0.00
2022-06-30 9.85 0 0.00
2022-03-31 9.80 0 0.00
2021-12-31 9.88 0 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.173B $0.029B
TriSalus Life Sciences Inc. is an oncology company integrating immunotherapy with disruptive delivery technology to transform the treatment paradigm for patients with liver and pancreatic tumors. TriSalus Life Sciences Inc., formerly known as MedTech Acquisition Corporation, is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $228.788B 27.51
Boston Scientific (BSX) United States $154.602B 38.70
Stryker (SYK) United States $144.385B 30.19
EssilorLuxottica (ESLOY) France $135.514B 0.00
Medtronic (MDT) Ireland $103.771B 14.71
Haleon (HLN) United Kingdom $49.845B 28.36
Lonza Group Ag (LZAGY) Switzerland $48.977B 0.00
ResMed (RMD) United States $35.996B 27.04
GE HealthCare Technologies (GEHC) United States $31.796B 15.10
Agilent Technologies (A) United States $31.270B 20.66
Terumo (TRUMY) Japan $27.864B 36.19
Insulet (PODD) United States $22.590B 88.67
Koninklijke Philips (PHG) Netherlands $21.684B 15.59
Zimmer Biomet Holdings (ZBH) United States $18.137B 11.65
Baxter (BAX) United States $15.534B 11.60
Smith & Nephew SNATS (SNN) United Kingdom $12.438B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.181B 21.51
Lantheus Holdings (LNTH) United States $5.172B 13.05
Prestige Consumer Healthcare (PBH) United States $4.201B 18.77
Perrigo (PRGO) Ireland $3.629B 9.20
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.218B 23.73
Haemonetics (HAE) United States $3.178B 14.48
Envista Holdings (NVST) United States $2.859B 23.76
GN Store Nord (GNNDY) Denmark $2.097B 17.37
QuidelOrtho (QDEL) United States $2.041B 14.04
LeMaitre Vascular (LMAT) United States $1.788B 39.96
AtriCure (ATRC) United States $1.624B 0.00
Neogen (NEOG) United States $1.343B 17.19
Acuren (TIC) United States $1.288B 0.00
AdaptHealth (AHCO) United States $1.206B 12.25
Green Thumb Industries (GTBIF) United States $1.175B 26.43
Kestra Medical Technologies (KMTS) United States $1.145B 0.00
BioLife Solutions (BLFS) United States $1.050B 0.00
Phibro Animal Health (PAHC) United States $0.933B 11.93
InMode (INMD) Israel $0.906B 9.13
CeriBell (CBLL) United States $0.624B 0.00
Evolus (EOLS) United States $0.616B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.584B 0.00
Curaleaf Holdings (CURLF) Canada $0.558B 0.00
Owens & Minor (OMI) United States $0.532B 4.41
Valneva SE (VALN) France $0.529B 0.00
Capricor Therapeutics (CAPR) United States $0.496B 0.00
Tilray Brands (TLRY) Canada $0.450B 0.00
Surmodics (SRDX) United States $0.417B 0.00
Canopy Growth (CGC) Canada $0.355B 0.00
SNDL (SNDL) Canada $0.344B 0.00
Cresco Labs (CRLBF) United States $0.336B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
VAREX IMAGING (VREX) United States $0.318B 11.71
Aurora Cannabis (ACB) Canada $0.309B 54.90
Sanara MedTech (SMTI) United States $0.275B 0.00
Viemed Healthcare (VMD) United States $0.258B 21.73
Sanuwave Health (SNWV) United States $0.247B 0.00
Verano Holdings (VRNOF) United States $0.244B 0.00
Cerus (CERS) United States $0.239B 0.00
ZimVie (ZIMV) United States $0.233B 10.57
Biote (BTMD) United States $0.205B 5.77
Brainsway (BWAY) Israel $0.197B 52.15
OraSure Technologies (OSUR) United States $0.192B 0.00
High Tide (HITI) Canada $0.189B 0.00
Omeros (OMER) United States $0.189B 0.00
Quanterix (QTRX) United States $0.188B 0.00
Organigram Global (OGI) Canada $0.183B 0.00
Utah Medical Products (UTMD) United States $0.174B 14.20
FitLife Brands (FTLF) United States $0.131B 16.18
Exagen (XGN) United States $0.128B 0.00
Jin Medical (ZJYL) China $0.124B 0.00
TerrAscend (TSNDF) Canada $0.117B 0.00
Agape ATP (ATPC) $0.112B 0.00
MacroGenics (MGNX) United States $0.100B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Fonar (FONR) United States $0.087B 11.17
Quipt Home Medical (QIPT) United States $0.075B 0.00
Veru (VERU) United States $0.072B 0.00
InterCure (INCR) Israel $0.071B 0.00
Zynex (ZYXI) United States $0.070B 0.00
Jushi Holdings (JUSHF) United States $0.064B 0.00
Apyx Medical (APYX) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.056B 0.00
Cytosorbents (CTSO) United States $0.053B 0.00
United Health Products (UEEC) United States $0.051B 0.00
Modular Medical (MODD) United States $0.045B 0.00
United-Guardian (UG) United States $0.037B 12.94
Rockwell Medical (RMTI) United States $0.034B 0.00
Safety Shot (SHOT) United States $0.028B 0.00
Nephros (NEPH) United States $0.028B 37.57
Allurion Technologies (ALUR) United States $0.022B 0.00
INLIF (INLF) $0.018B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Senestech (SNES) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00